Reappraisal of GIK in Acute STEMI by Pre-hospital Administration

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 334 participants.

Also called NCT02591927

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 334 participants (planned count) (from the registry)
Sponsor
Centre Hospitalier Universitaire Vaudois (from the registry)
Registry
  • NCT NCT02591927
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
Not reported
Countries
Switzerland (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02591927. Randomized; quadruple masking; primary purpose treatment. Start 2016-02 (registry gives no type); primary completion 2019-02 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Reappraisal of GIK in Acute STEMI by Pre-hospital Administration
Acronym
REAGIK-STEMI
Intervention (Drug)
Glucose-Insulin-Potassium
Intervention (Drug)
Glucose 5%
Lead sponsor
Centre Hospitalier Universitaire Vaudois (class: other)

Record details

Record id
cardio:ct-nct02591927
Content hash
06e0396322ddeefeb3cbdd8a6fc116a398db8f8e0c306f27a4da7df9ff65c752